arrow
N

Navonil De Sarkar

medical college of wisconsin
H指数:23
被引数:5,864

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Beyond BRCAness: ATM pathway defects confer sensitivity to topoisomerase I inhibition

超越BRCAness:ATM通路缺陷赋予拓扑异构酶I抑制剂敏感性

2026-09-150
OAAI
Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer

同时发生的BRCA2/SPOP突变可预测转移性去势抵抗性前列腺癌中特殊的聚 (ADP-核糖) 聚合酶抑制剂敏感性

2024-08-015
PRE
Assessment of TROP2, CEACAM5 and DLL3 in metastatic prostate cancer: Expression landscape and molecular correlates
2024-05-173
OAAI
Bipolar androgen therapy plus olaparib in men with metastatic castration-resistant prostate cancer
2022-12-239
OA
A framework for clinical cancer subtyping from nucleosome profiling of cell-free DNA
2022-12-0338
OAAI
Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes
2022-11-1826
OAAI
Genomic attributes of homology-directed DNA repair deficiency in metastatic prostate cancer
2021-12-0815
OA
Selective androgen receptor modulators activate the canonical prostate cancer androgen receptor program and repress cancer growth
2021-05-1730
OA
Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer
2021-03-3087
OAAI
Regulation of CEACAM5 and Therapeutic Efficacy of an Anti-CEACAM5-SN38 Antibody-drug Conjugate in Neuroendocrine Prostate Cancer

CEACAM5的调控和Anti-CEACAM5-SN38抗体-药物偶联物在神经内分泌前列腺癌中的治疗作用

2021-02-0143
OAAI
Genomic correlates of clinical outcome in advanced prostate cancer

晚期前列腺癌临床预后的基因组相关性

2019-05-06901
OAAI